Biogenesis has been selected as one of a few companies to participate in Memorial Sloan Kettering Cancer Center's inaugural Innovation Hub, to work together with MSK on innovative technologies designed to support decentralized clinical trials. We started Biogenesis to build end-to-end tooling for clinical trial operations across our vast network of research sites. We are proud to say that Biogenesis today is a platform loved and used by sites nationwide.

The iHub Challenge is a three-month program that brings together a cohort of cutting-edge companies to work with MSK clinical and digital health experts on innovation initiatives. Each cohort centers around a unique theme, with this year’s theme aimed at improving remote delivery of clinical care.

With our participation in this MSK program, we are spending the few months working closely with their clinical trial expert operators, identifying and developing solutions for clinops at large academic centers, cumulating in our launch of a clinical trial management platform for academic centers and hospitals globally.

More updates will follow as they become available.